malondialdehyde has been researched along with glucagon-like peptide 1 (7-36) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Feng, W; Qian, Z; Wang, Q; Xu, J; Yin, X; Zhao, L | 1 |
1 other study(ies) available for malondialdehyde and glucagon-like peptide 1 (7-36)
| Article | Year |
|---|---|
Protective effect of rhGLP-1 (7-36) on brain ischemia/reperfusion damage in diabetic rats.
Topics: Animals; Blood Glucose; Brain; Brain Ischemia; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucagon-Like Peptide 1; Glutathione Peroxidase; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Neuroprotective Agents; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptide Fragments; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury; Severity of Illness Index; Superoxide Dismutase | 2015 |